Aarti Bhatia

1.0k total citations · 1 hit paper
33 papers, 580 citations indexed

About

Aarti Bhatia is a scholar working on Otorhinolaryngology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Aarti Bhatia has authored 33 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Otorhinolaryngology, 15 papers in Oncology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Aarti Bhatia's work include Head and Neck Cancer Studies (21 papers), Lung Cancer Treatments and Mutations (10 papers) and Cancer Diagnosis and Treatment (5 papers). Aarti Bhatia is often cited by papers focused on Head and Neck Cancer Studies (21 papers), Lung Cancer Treatments and Mutations (10 papers) and Cancer Diagnosis and Treatment (5 papers). Aarti Bhatia collaborates with scholars based in United States, Canada and France. Aarti Bhatia's co-authors include Barbara Burtness, Saral Mehra, Benjamin L. Judson, Wendell G. Yarbrough, Shayan Cheraghlou, Zain Husain, Henry S. Park, Kie‐Kian Ang, Adam S. Garden and Steven I. Sherman and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Aarti Bhatia

31 papers receiving 577 citations

Hit Papers

Treating Head and Neck Cancer in the Age of Immunotherapy... 2023 2026 2024 2025 2023 25 50 75 100

Peers

Aarti Bhatia
Aarti Bhatia
Citations per year, relative to Aarti Bhatia Aarti Bhatia (= 1×) peers Maria Carmela Pedicillo

Countries citing papers authored by Aarti Bhatia

Since Specialization
Citations

This map shows the geographic impact of Aarti Bhatia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aarti Bhatia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aarti Bhatia more than expected).

Fields of papers citing papers by Aarti Bhatia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aarti Bhatia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aarti Bhatia. The network helps show where Aarti Bhatia may publish in the future.

Co-authorship network of co-authors of Aarti Bhatia

This figure shows the co-authorship network connecting the top 25 collaborators of Aarti Bhatia. A scholar is included among the top collaborators of Aarti Bhatia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aarti Bhatia. Aarti Bhatia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bhatia, Aarti, Ranee Mehra, Jessica R. Bauman, et al.. (2025). Phase II Trial of Chemotherapy, Cetuximab, and Erlotinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck. Head & Neck. 47(9). 2373–2382. 2 indexed citations
2.
Bhatia, Aarti, et al.. (2025). Head and neck cancer – emerging targeted therapies. Frontiers in Oncology. 15. 1640960–1640960.
3.
Lee, Daniel Y., et al.. (2025). Real world treatment patterns for recurrent and metastatic head and neck cancer in the post-KEYNOTE 048 era. Frontiers in Oncology. 15. 1577509–1577509.
4.
Roof, Scott A., Glenn J. Hanna, Eleni M. Rettig, et al.. (2024). The NAVigate-HPV Registry: A comprehensive biomarker evidence base for HPV-driven cancers.. Journal of Clinical Oncology. 42(16_suppl). e15045–e15045. 1 indexed citations
5.
Bhatia, Aarti, Hidetoshi Hayashi, Takahiro Kogawa, et al.. (2024). HERTHENA-PanTumor01: A global, multicohort, phase 2 trial of HER3-DXd in relapsed/refractory metastatic solid tumors.. Journal of Clinical Oncology. 42(16_suppl). TPS3164–TPS3164. 1 indexed citations
7.
Bauman, Julie E., Nabil F. Saba, Denise J. Roe, et al.. (2023). Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer. Journal of Clinical Oncology. 41(22). 3851–3862. 25 indexed citations
8.
Bhatia, Aarti & Barbara Burtness. (2023). Treating Head and Neck Cancer in the Age of Immunotherapy: A 2023 Update. Drugs. 83(3). 217–248. 106 indexed citations breakdown →
9.
Bhatia, Aarti. (2022). Targeting Epidermal Growth Factor Receptor in Head and Neck Cancer. The Cancer Journal. 28(5). 331–338. 5 indexed citations
12.
Hayman, Thomas J., Aarti Bhatia, Krishan R. Jethwa, Melissa R. Young, & Henry S. Park. (2021). Combinations of immunotherapy and radiation therapy in head and neck squamous cell carcinoma: a narrative review. Translational Cancer Research. 10(5). 2571–2585. 10 indexed citations
13.
Bauman, Julie E., Nabil F. Saba, Denise J. Roe, et al.. (2021). Randomized phase II trial of ficlatuzumab with or without cetuximab in pan-refractory, advanced head and neck squamous cell carcinoma (HNSCC).. Journal of Clinical Oncology. 39(15_suppl). 6015–6015. 3 indexed citations
14.
Loganadane, Gokoulakrichenane, Benjamin H. Kann, Henry S. Park, et al.. (2019). Clinical Outcomes of Head and Neck Cancer Patients Who Undergo Resection, But Forgo Adjuvant Therapy. Anticancer Research. 39(9). 4885–4890. 9 indexed citations
15.
Loganadane, Gokoulakrichenane, Benjamin H. Kann, Skyler B. Johnson, et al.. (2019). Clinical Outcomes of Head and Neck Cancer Patients who Undergo Resection, but Forgo Adjuvant Therapy. International Journal of Radiation Oncology*Biology*Physics. 105(1). E375–E376. 1 indexed citations
16.
Cheraghlou, Shayan, Phoebe Kuo, Saral Mehra, et al.. (2018). Adjuvant therapy in major salivary gland cancers: Analysis of 8580 patients in the National Cancer Database. Head & Neck. 40(7). 1343–1355. 51 indexed citations
17.
Biktasova, Asel, Michael Hajek, Andrew K. Sewell, et al.. (2017). Demethylation Therapy as a Targeted Treatment for Human Papillomavirus–Associated Head and Neck Cancer. Clinical Cancer Research. 23(23). 7276–7287. 46 indexed citations
18.
Fujiwara, Rance J. T., Barbara Burtness, Zain Husain, et al.. (2017). Treatment guidelines and patterns of care in oral cavity squamous cell carcinoma: Primary surgical resection vs. nonsurgical treatment. Oral Oncology. 71. 129–137. 22 indexed citations
19.
Bhatia, Aarti & Barbara Burtness. (2017). Novel Molecular Targets for Chemoprevention in Malignancies of the Head and Neck. Cancers. 9(9). 113–113. 16 indexed citations
20.
Bhatia, Aarti, Archana Rao, Kie‐Kian Ang, et al.. (2009). Anaplastic thyroid cancer: Clinical outcomes with conformal radiotherapy. Head & Neck. 32(7). 829–836. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026